person · Reporting owner

SIGAL ELLIOT

Disclosed activity across 3 companies

Tapewire entity: 16624
SEC CIK: 0001202294

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
BRISTOL MYERS SQUIBB COBMY · Entity 1662	Director · EVP, CSO & President R&D	June 03, 2013	June 05, 2013

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BRISTOL MYERS SQUIBB CO

Report date June 03, 2013 · Filed June 05, 2013

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, $0.10 par valueSEC Table I · non-derivative	Direct	148,221	Ending reported balance After 2013-06-03 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2013-06-03 · Exercise / conversion · Acquired 98,875 · Balance 231,868 Row 2 · 2013-06-03 · Sale · Disposed 83,647 · Balance 148,221 F1: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $47.83 to $48.62, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Executive Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.01 · Expires 2017-03-05	Direct	25,000	Reported balance After 2013-06-03 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2013-06-03 · Exercise / conversion · Disposed 98,875 · Balance 25,000 F3: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 6, 2007.
Common Stock, $0.10 par valueSEC Table I · non-derivative	IndirectBy BMY Savings & Investment Program	1,628.06	Reported balance Holding disclosure · report date 2013-06-03 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 1,628.06 F2: Based on a plan statement as of the end of the most recent fiscal quarter.
Common Stock, $0.10 par valueSEC Table I · non-derivative	IndirectBy C. Elliott Sigal 2012 Irrevocable Trust	18,180	Reported balance Holding disclosure · report date 2013-06-03 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 18,180
Common Stock, $0.10 par valueSEC Table I · non-derivative	IndirectBy Ruth L. Sigal Irrevocable Trust	18,180	Reported balance Holding disclosure · report date 2013-06-03 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 18,180
Common Stock, $0.10 par valueSEC Table I · non-derivative	IndirectBy Sigal Family Investments, LLC	9,091	Reported balance Holding disclosure · report date 2013-06-03 · row 6 Holding and transaction disclosures are not merged. 1 source row Row 6 · Balance 9,091

Filing footnotes · ownership attribution and instrument terms

F1: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $47.83 to $48.62, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F2: Based on a plan statement as of the end of the most recent fiscal quarter.

F3: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 6, 2007.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Mead Johnson Nutrition Co

Report date June 15, 2017 · Filed June 15, 2017

Section 16 reporting ended · disclosed 2017-06-15. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2017-06-15 transaction · row 1 1 source row Row 1 · 2017-06-15 · Disposition to issuer · Disposed 13,721 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc, and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share.
Common StockSEC Table I · non-derivative	IndirectBy Sigal Family Investments, LLC	Reported balance After 2017-06-15 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2017-06-15 · Disposition to issuer · Disposed 2,590 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc, and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share.
Common StockSEC Table I · non-derivative	IndirectBy the C. Elliott Sigal 2012 Irrevocable Trust	Reported balance After 2017-06-15 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2017-06-15 · Disposition to issuer · Disposed 5,180 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc, and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share.
Common StockSEC Table I · non-derivative	IndirectBy the Ruth L. Sigal 2012 Irrevocable Trust	Reported balance After 2017-06-15 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 4 · 2017-06-15 · Disposition to issuer · Disposed 5,180 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc, and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2017-06-15 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2017-06-15 · Disposition to issuer · Disposed 1,709 · Balance 0 F2: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock. F3: This RSU was originally scheduled to vest on February 28, 2018. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc, and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share.

F2: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock.

F3: This RSU was originally scheduled to vest on February 28, 2018. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share.

Spark Therapeutics, Inc.

Report date December 17, 2019 · Filed December 17, 2019

Section 16 reporting ended · disclosed 2019-12-17. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2019-12-17 transaction · row 1 1 source row Row 1 · 2019-12-17 · Other · Disposed 14,214 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated February 22, 2019, by and between Spark Therapeutics, Inc. ("Spark"), Roche Holdings, Inc. ("Roche") and 022019 Merger Subsidiary, Inc. ("Merger Sub") (the "Merger Agreement" and the transactions contemplated thereby, the "Merger"), whereby Roche caused Merger Sub to conduct a tender offer for all of the issued and outstanding shares of common stock, par value $0.001 per share, of Spark, at a price of $114.50 per share. On December 17, 2019, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $81.53 · Expires 2028-05-29	Direct	Reported balance After 2019-12-17 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2019-12-17 · Disposition to issuer · Disposed 4,000 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.93 · Expires 2027-05-30	Direct	Reported balance After 2019-12-17 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2019-12-17 · Disposition to issuer · Disposed 4,000 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.22 · Expires 2026-05-31	Direct	Reported balance After 2019-12-17 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2019-12-17 · Disposition to issuer · Disposed 6,000 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.45 · Expires 2024-08-11	Direct	Reported balance After 2019-12-17 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2019-12-17 · Disposition to issuer · Disposed 17,203 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.45 · Expires 2024-06-10	Direct	Reported balance After 2019-12-17 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2019-12-17 · Disposition to issuer · Disposed 25,786 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to the Agreement and Plan of Merger, dated February 22, 2019, by and between Spark Therapeutics, Inc. ("Spark"), Roche Holdings, Inc. ("Roche") and 022019 Merger Subsidiary, Inc. ("Merger Sub") (the "Merger Agreement" and the transactions contemplated thereby, the "Merger"), whereby Roche caused Merger Sub to conduct a tender offer for all of the issued and outstanding shares of common stock, par value $0.001 per share, of Spark, at a price of $114.50 per share. On December 17, 2019, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn.

F2: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
March 06, 2012 Filed Mar 9, 2012 02:27 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionPerformance Shares · Derivative	78,955	$0.00	$0.00	Disclosure SEC source: 0001225208-12-007115 · doc4.xml · derivative · entry 10 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,972.9577 Underlying: Common Stock, $0.10 par value · 78,955 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F1 · shares: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. F11 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F11 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F15 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2010-2012 Long-Term Performance Award only. Read SEC document
March 06, 2012 Filed Mar 9, 2012 02:27 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	OtherPerformance Shares · Derivative	2,879.4177	$0.00	$0.00	Disclosure SEC source: 0001225208-12-007115 · doc4.xml · derivative · entry 9 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,927.9577 Underlying: Common Stock, $0.10 par value · 2,879.4177 shares Expires not disclosed F13 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F14 · shares: Represents dividend equivalents earned under the 2010-2012 Long Term Performance Award. F13 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F13 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F10 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. Read SEC document
March 06, 2012 Filed Mar 9, 2012 02:27 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	GrantPerformance Shares · Derivative	28,152	$0.00	$0.00	Disclosure SEC source: 0001225208-12-007115 · doc4.xml · derivative · entry 8 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,048.54 Underlying: Common Stock, $0.10 par value · 28,152 shares Expires not disclosed F11 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F12 · shares: Represents performance shares earned under the 2009-2011 Long-Term Performance Award. F11 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F11 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F10 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. Read SEC document
March 06, 2012 Filed Mar 9, 2012 02:27 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	GrantPerformance Shares · Derivative	33,783	$0.00	$0.00	Disclosure SEC source: 0001225208-12-007115 · doc4.xml · derivative · entry 7 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,896.54 Underlying: Common Stock, $0.10 par value · 33,783 shares Expires not disclosed F8 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F9 · shares: Represents performance shares earned under the 2010-2012 Long-Term Performance Award. F8 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F8 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F10 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. Read SEC document
March 06, 2012 Filed Mar 9, 2012 02:27 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	GrantMarket Share Units · Derivative	35,207	$0.00	$0.00	Disclosure SEC source: 0001225208-12-007115 · doc4.xml · derivative · entry 6 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,207 Underlying: Common Stock, $0.10 par value · 35,207 shares Expires 2016-03-06 F6 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F7 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. F7 · derivative.expiration_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document
March 06, 2012 Filed Mar 9, 2012 02:27 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	36,597	$32.33	$1,183,181.01	Disclosure SEC source: 0001225208-12-007115 · doc4.xml · nonDerivative · entry 4 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,840 F4 · shares: Shares withheld for payment of taxes upon distribution of the 2009-2011 Long-Term Performance Award. Read SEC document
March 06, 2012 Filed Mar 9, 2012 02:27 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	3,187	$32.33	$103,035.71	Disclosure SEC source: 0001225208-12-007115 · doc4.xml · nonDerivative · entry 3 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,437 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document
March 06, 2012 Filed Mar 9, 2012 02:27 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	6,875	$0.00	$0.00	Disclosure SEC source: 0001225208-12-007115 · doc4.xml · nonDerivative · entry 2 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents vesting of one-third of restricted stock units granted on March 6, 2007. This award has fully vested. Read SEC document
March 06, 2012 Filed Mar 9, 2012 02:27 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	78,955	$0.00	$0.00	Disclosure SEC source: 0001225208-12-007115 · doc4.xml · nonDerivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. Read SEC document
March 04, 2012 Filed Mar 6, 2012 00:43 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionRestricted Stock Units · Derivative	7,453	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-12-006731 · doc4.xml · derivative · entry 15 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,453 Underlying: Common Stock, $0.10 par value · 7,453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F7 · derivative.exercise_date: Represents vesting of one-third of restricted stock units granted on March 4, 2008. The balance of the award is scheduled to vest on the fifth anniversary of the grant date. F7 · derivative.expiration_date: Represents vesting of one-third of restricted stock units granted on March 4, 2008. The balance of the award is scheduled to vest on the fifth anniversary of the grant date. Read SEC document
March 04, 2012 Filed Mar 6, 2012 00:43 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	3,455	$32.59	$112,598.45	Disclosure SEC source: 0001225208-12-006731 · doc4.xml · nonDerivative · entry 10 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,794 F6 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document
March 04, 2012 Filed Mar 6, 2012 00:43 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	7,453	$0.00	$0.00	Disclosure SEC source: 0001225208-12-006731 · doc4.xml · nonDerivative · entry 9 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · shares: Represents vesting of one-third of restricted stock units granted on March 4, 2008. The balance of the award is scheduled to vest on the fifth anniversary of the grant date. Read SEC document
March 03, 2012 Filed Mar 6, 2012 00:43 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionRestricted Stock Units · Derivative	46,365	$0.00	$0.00	Disclosure SEC source: 0001225208-12-006731 · doc4.xml · derivative · entry 14 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,732 Underlying: Common Stock, $0.10 par value · 46,365 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F5 · derivative.exercise_date: Represents vesting of one-third of restricted stock units granted on March 3, 2009. The balance of the awards are scheduled to vest in two equal installments on the fourth and fifth anniversaries of the grant date. F5 · derivative.expiration_date: Represents vesting of one-third of restricted stock units granted on March 3, 2009. The balance of the awards are scheduled to vest in two equal installments on the fourth and fifth anniversaries of the grant date. Read SEC document
March 03, 2012 Filed Mar 6, 2012 00:43 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	21,491	$32.59	$700,391.69	Disclosure SEC source: 0001225208-12-006731 · doc4.xml · nonDerivative · entry 8 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,796 F6 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document
March 03, 2012 Filed Mar 6, 2012 00:43 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	46,365	$0.00	$0.00	Disclosure SEC source: 0001225208-12-006731 · doc4.xml · nonDerivative · entry 7 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,287 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents vesting of one-third of restricted stock units granted on March 3, 2009. The balance of the awards are scheduled to vest in two equal installments on the fourth and fifth anniversaries of the grant date. Read SEC document
March 02, 2012 Filed Mar 6, 2012 00:43 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionMarket Share Units · Derivative	12,062	$0.00	$0.00	Disclosure SEC source: 0001225208-12-006731 · doc4.xml · derivative · entry 13 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,268 Underlying: Common Stock, $0.10 par value · 12,062 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. F4 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. F10 · balance_after: Represents an aggregate of the derivative securities beneficially owned under the awards granted on March 2, 2010 and March 1, 2011. Read SEC document
March 02, 2012 Filed Mar 6, 2012 00:43 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	7,383	$32.59	$240,611.97	Disclosure SEC source: 0001225208-12-006731 · doc4.xml · nonDerivative · entry 6 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,922 F3 · shares: Shares withheld for payment of taxes upon vesting of market share units. Read SEC document
March 02, 2012 Filed Mar 6, 2012 00:43 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	OtherCommon Stock, $0.10 par value	3,866	$0.00	$0.00	Disclosure SEC source: 0001225208-12-006731 · doc4.xml · nonDerivative · entry 5 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,305 F2 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document
March 02, 2012 Filed Mar 6, 2012 00:43 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	12,062	$0.00	$0.00	Disclosure SEC source: 0001225208-12-006731 · doc4.xml · nonDerivative · entry 4 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. Read SEC document
March 01, 2012 Filed Mar 6, 2012 00:43 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionMarket Share Units · Derivative	11,714	$0.00	$0.00	Disclosure SEC source: 0001225208-12-006731 · doc4.xml · derivative · entry 12 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,330 Underlying: Common Stock, $0.10 par value · 11,714 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date. F1 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date. F10 · balance_after: Represents an aggregate of the derivative securities beneficially owned under the awards granted on March 2, 2010 and March 1, 2011. Read SEC document
March 01, 2012 Filed Mar 6, 2012 00:43 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	5,412	$32.64	$176,647.68	Disclosure SEC source: 0001225208-12-006731 · doc4.xml · nonDerivative · entry 3 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,377 F3 · shares: Shares withheld for payment of taxes upon vesting of market share units. Read SEC document
March 01, 2012 Filed Mar 6, 2012 00:43 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	OtherCommon Stock, $0.10 par value	3,173	$0.00	$0.00	Disclosure SEC source: 0001225208-12-006731 · doc4.xml · nonDerivative · entry 2 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,789 F2 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document
March 01, 2012 Filed Mar 6, 2012 00:43 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	11,714	$0.00	$0.00	Disclosure SEC source: 0001225208-12-006731 · doc4.xml · nonDerivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date. Read SEC document
May 18, 2011 Filed May 18, 2011 23:12 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionExecutive Option (right to buy) · Derivative	37,831	$28.70 Strike: $22.14	$1,085,791.31	Disclosure SEC source: 0001225208-11-014779 · doc4.xml · derivative · entry 14 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,478 Underlying: Common Stock, $0.10 par value · 37,831 shares Expires 2018-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Twenty-five percent of the stock option award vests on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document
May 18, 2011 Filed May 18, 2011 23:12 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionExecutive Option (right to buy) · Derivative	147,748	$28.70 Strike: $17.51	$4,240,530.12	Disclosure SEC source: 0001225208-11-014779 · doc4.xml · derivative · entry 13 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,749 Underlying: Common Stock, $0.10 par value · 147,748 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Twenty-five percent of the stock option award vests on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document
May 18, 2011 Filed May 18, 2011 23:12 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	119,321	$28.70	$3,424,643.95	Disclosure SEC source: 0001225208-11-014779 · doc4.xml · nonDerivative · entry 9 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,902 F4 · shares: Shares withheld for payment of exercise price upon exercise of stock options. F5 · price: This transaction was executed in multiple trades from $28.7000 to $28.7150. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
May 18, 2011 Filed May 18, 2011 23:12 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	30,978	$28.70	$889,102.68	Disclosure SEC source: 0001225208-11-014779 · doc4.xml · nonDerivative · entry 8 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,223 F2 · shares: Shares withheld for payment of taxes and fees upon exercise of stock options. F5 · price: This transaction was executed in multiple trades from $28.7000 to $28.7150. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
May 18, 2011 Filed May 18, 2011 23:12 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	SaleCommon Stock, $0.10 par value	730	$28.70	$20,951.80	Disclosure SEC source: 0001225208-11-014779 · doc4.xml · nonDerivative · entry 7 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,201 F5 · price: This transaction was executed in multiple trades from $28.7000 to $28.7150. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
May 18, 2011 Filed May 18, 2011 23:12 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	185,579	$28.70	$5,326,321.44	Disclosure SEC source: 0001225208-11-014779 · doc4.xml · nonDerivative · entry 6 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 16, 2011 Filed May 18, 2011 23:12 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionOption (right to buy) · Derivative	68,000	$28.90 Strike: $23.14	$1,965,295.20	Disclosure SEC source: 0001225208-11-014779 · doc4.xml · derivative · entry 12 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 68,000 shares Expires 2013-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Currently exercisable. Read SEC document
May 16, 2011 Filed May 18, 2011 23:12 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionExecutive Option (right to buy) · Derivative	191,600	$28.90 Strike: $22.14	$5,537,508.24	Disclosure SEC source: 0001225208-11-014779 · doc4.xml · derivative · entry 11 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,309 Underlying: Common Stock, $0.10 par value · 191,600 shares Expires 2018-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Twenty-five percent of the stock option award vests on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document
May 16, 2011 Filed May 18, 2011 23:12 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	201,220	$28.90	$5,815,539.71	Disclosure SEC source: 0001225208-11-014779 · doc4.xml · nonDerivative · entry 5 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,352 F4 · shares: Shares withheld for payment of exercise price upon exercise of stock options. F1 · price: This transaction was executed in multiple trades from $28.9000 to $28.9300. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
May 16, 2011 Filed May 18, 2011 23:12 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	SaleCommon Stock, $0.10 par value	70,450	$28.90	$2,036,005.00	Disclosure SEC source: 0001225208-11-014779 · doc4.xml · nonDerivative · entry 4 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,572 F3 · price: This transaction was executed in multiple trades from $28.9000 to $28.9050. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
May 16, 2011 Filed May 18, 2011 23:12 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	27,461	$28.90	$793,661.35	Disclosure SEC source: 0001225208-11-014779 · doc4.xml · nonDerivative · entry 3 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 443,022 F2 · shares: Shares withheld for payment of taxes and fees upon exercise of stock options. F1 · price: This transaction was executed in multiple trades from $28.9000 to $28.9300. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
May 16, 2011 Filed May 18, 2011 23:12 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	SaleCommon Stock, $0.10 par value	355	$28.90	$10,260.00	Disclosure SEC source: 0001225208-11-014779 · doc4.xml · nonDerivative · entry 2 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470,483 F1 · price: This transaction was executed in multiple trades from $28.9000 to $28.9300. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
May 16, 2011 Filed May 18, 2011 23:12 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	259,600	$28.90	$7,502,803.44	Disclosure SEC source: 0001225208-11-014779 · doc4.xml · nonDerivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 07, 2011 Filed Mar 8, 2011 22:32 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	3,554	$26.31	$93,505.74	Disclosure SEC source: 0001225208-11-009172 · doc4.xml · nonDerivative · entry 5 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,238 F4 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. Read SEC document
March 06, 2011 Filed Mar 8, 2011 22:32 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionRestricted Stock Units · Derivative	6,875	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-11-009172 · doc4.xml · derivative · entry 8 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock, $0.10 par value · 6,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F7 · derivative.exercise_date: Shares consist of restricted stock units with one-third vesting on each of the third, forth, and fifth anniversaries of the grant date. F7 · derivative.expiration_date: Shares consist of restricted stock units with one-third vesting on each of the third, forth, and fifth anniversaries of the grant date. Read SEC document
March 06, 2011 Filed Mar 8, 2011 22:32 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	3,187	$26.43	$84,232.41	Disclosure SEC source: 0001225208-11-009172 · doc4.xml · nonDerivative · entry 4 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,792 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document
March 06, 2011 Filed Mar 8, 2011 22:32 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	6,875	$0.00	$0.00	Disclosure SEC source: 0001225208-11-009172 · doc4.xml · nonDerivative · entry 3 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares acquired upon vesting of restricted stock units. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document
March 04, 2011 Filed Mar 8, 2011 22:32 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionRestricted Stock Units · Derivative	7,452	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-11-009172 · doc4.xml · derivative · entry 7 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,906 Underlying: Common Stock, $0.10 par value · 7,452 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F7 · derivative.exercise_date: Shares consist of restricted stock units with one-third vesting on each of the third, forth, and fifth anniversaries of the grant date. F7 · derivative.expiration_date: Shares consist of restricted stock units with one-third vesting on each of the third, forth, and fifth anniversaries of the grant date. Read SEC document
March 04, 2011 Filed Mar 8, 2011 22:32 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	3,455	$26.43	$91,315.65	Disclosure SEC source: 0001225208-11-009172 · doc4.xml · nonDerivative · entry 2 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,104 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document
March 04, 2011 Filed Mar 8, 2011 22:32 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	7,452	$0.00	$0.00	Disclosure SEC source: 0001225208-11-009172 · doc4.xml · nonDerivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,559 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares acquired upon vesting of restricted stock units. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document
March 02, 2011 Filed Mar 5, 2011 00:04 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionMarket Share Units · Derivative	12,062	$0.00	$0.00	Disclosure SEC source: 0001225208-11-008872 · doc4.xml · derivative · entry 5 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,044 Underlying: Common Stock, $0.10 par value · 12,062 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock based on the average of the closing share price of the company's common stock on the vesting date and the nine trading days immediately preceding the vesting date. F6 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a performance factor. F6 · derivative.expiration_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a performance factor. Read SEC document
March 02, 2011 Filed Mar 5, 2011 00:04 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	5,796	$0.00	$0.00	Disclosure SEC source: 0001225208-11-008872 · doc4.xml · nonDerivative · entry 3 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,107 F3 · shares: Shares withheld for payment of taxes upon vesting of market share units. Read SEC document
March 02, 2011 Filed Mar 5, 2011 00:04 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	OtherCommon Stock, $0.10 par value	441	$0.00	$0.00	Disclosure SEC source: 0001225208-11-008872 · doc4.xml · nonDerivative · entry 2 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,903 F2 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document
March 02, 2011 Filed Mar 5, 2011 00:04 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	12,062	$0.00	$0.00	Disclosure SEC source: 0001225208-11-008872 · doc4.xml · nonDerivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares acquired upon vesting of market share units. Read SEC document
March 02, 2011 Filed Mar 16, 2011 20:34 UTC Amendment	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	5,796	$25.39	$147,160.44	Disclosure SEC source: 0001225208-11-009871 · doc4a.xml · nonDerivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,107 F1 · shares: This Form 4 is amended to report the correct price for the shares withheld for payment of taxes upon vesting of market share units. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document
March 01, 2011 Filed Mar 4, 2011 02:52 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionPerformance Shares · Derivative	116,000	$0.00	$0.00	Disclosure SEC source: 0001225208-11-008700 · doc4.xml · derivative · entry 10 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,113.54 Underlying: Common Stock, $0.10 par value · 116,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011. F1 · shares: Consists of performance shares earned under the 2008-2010 Regular Long-Term Performance Award and the 2008-2010 Special Long-Term Performance Award. F7 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011. F7 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011. Read SEC document
March 01, 2011 Filed Mar 4, 2011 02:52 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	OtherPerformance Shares · Derivative	1,473.54	$0.00	$0.00	Disclosure SEC source: 0001225208-11-008700 · doc4.xml · derivative · entry 9 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,113.54 Underlying: Common Stock, $0.10 par value · 1,473.54 shares Expires not disclosed F12 · derivative.exercise_price: Shares represent dividend equivalents earned under the 2010-2012 regular performance share unit award and will convert into one share of common stock upon payout in the first quarter of 2013. F12 · shares: Shares represent dividend equivalents earned under the 2010-2012 regular performance share unit award and will convert into one share of common stock upon payout in the first quarter of 2013. F12 · derivative.exercise_date: Shares represent dividend equivalents earned under the 2010-2012 regular performance share unit award and will convert into one share of common stock upon payout in the first quarter of 2013. F12 · derivative.expiration_date: Shares represent dividend equivalents earned under the 2010-2012 regular performance share unit award and will convert into one share of common stock upon payout in the first quarter of 2013. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.